PubMed · 2011 · 47 citations · 16 references
MedicineCell BiologyOncologyCell ProliferationCell SignalingMolecular OncologyCancer Cell SignalingCancer ChemopreventionCancer MetabolismColorectal CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerCancer Cell Proliferation InhibitionCancer Signaling PathwaysCell Growth Signaling PathwaysPhosphatase Inhibition
A report that effects of butyrate on some cells may be mediated by activation of AMP-activated protein kinase (AMPK) prompted this study which examines if other AMPK activators can induce differentiation and inhibit proliferation of colon cancer cells in a manner similar to butyrate. Using induction of alkaline phosphatase as a marker, it was observed that compound C, an AMPK inhibitor, is able to reduce the differentiating effect of butyrate on SW1116 and Caco-2 colon cancer cells. Metformin was observed to be less effective than butyrate in the induction of alkaline phosphatase but was more effective as a growth inhibitor. Phenformin was found to be a more potent growth inhibitor than metformin and both compounds cause acidification of the medium when incubated with colon cancer cells. Combined incubation of 2-deoxyglucose with either of the biguanides prevented the acidification of the medium but enhanced the growth inhibitory effects.
16
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 5.4K citations
Luying Peng, Zhongrong Li, Robert S. Green et al. · Journal of Nutrition · 2009 · 2K citations · Full text
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer, Christian Meier, Stephan Krähenbühl et al. · Diabetes Care · 2010 · 461 citations · Full text
Medicine, Oncology, Pharmacology +15